WASHINGTON — A dietary intervention to reduce sodium intake did not reduce clinical events in ambulatory patients with HF, although researchers saw a modest benefit in quality of life measures, data from the SODIUM-HF trial show.
“Patients and their clinicians should have realistic expectations of the benefits of lowering dietary sodium,” Justin Ezekowitz, MB, BCH, MSc, FRCPC, FACC, FAHA, FESC, told Healio at the American College of Cardiology Scientific Session where the data were presented. “Guidelines should consider this information as the largest and longest trial